Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -4.99 |
peg ratio | 0.16 |
price to book ratio | 1.62 |
price to sales ratio | 37,842.73 |
enterprise value multiple | -13.32 |
price fair value | 1.62 |
profitability ratios | |
---|---|
gross profit margin | -2933.33% |
operating profit margin | -373500.0% |
pretax profit margin | -347600.0% |
net profit margin | -347600.0% |
return on assets | -30.33% |
return on equity | -60.28% |
return on capital employed | -34.9% |
liquidity ratio | |
---|---|
current ratio | 15.01 |
quick ratio | 15.01 |
cash ratio | 14.90 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 243.33 |
days of payables outstanding | 1,810.96 |
cash conversion cycle | -1,567.63 |
receivables turnover | 1.50 |
payables turnover | 0.20 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.00 |
debt equity ratio | 0.00 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.00 |
interest coverage | -2,241.00 |
cash flow to debt ratio | 0.00 |
cash flow ratios | |
---|---|
free cash flow per share | -1.85 |
cash per share | 6.37 |
operating cash flow per share | -1.83 |
free cash flow operating cash flow ratio | 1.01 |
cash flow coverage ratios | 0.00 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -108.24 |
Frequently Asked Questions
Benitec Biopharma Inc. (BNTC) published its most recent earnings results on 26-09-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Benitec Biopharma Inc. (NASDAQ:BNTC)'s trailing twelve months ROE is -60.28%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Benitec Biopharma Inc. (BNTC) currently has a ROA of -30.33%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
BNTC reported a profit margin of -347600.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 15.01 in the most recent quarter. The quick ratio stood at 15.01, with a Debt/Eq ratio of 0.00.